BR 04-3 DEVELOPMENT OF NEW ANGIOTENSIN RECEPTOR BLOCKER.

@article{Choe2016BR0D,
  title={BR 04-3 DEVELOPMENT OF NEW ANGIOTENSIN RECEPTOR BLOCKER.},
  author={S. Choe},
  journal={Journal of hypertension},
  year={2016},
  volume={34 Suppl 1},
  pages={e199}
}
  • S. Choe
  • Published 2016
  • Medicine
  • Journal of hypertension
There are several classes of anti-hypertensive agents in the world, the most recently developed agent is angiotensin receptor blocker (ARB). There are already 8 ARBs in the market, but still medical unmet need for treatment of hypertension is existed. The 'ideal' anti-hypertensive agent would have a number of characteristics: (1) effective in lowering blood pressure to recommend goals; (2) high efficacy as monotherapy; (3) rapid onset of effect; (4) convenient once-daily administration to… Expand